Pricing drugs, selling hype and how we got here in the first place
May 15, 2018 - 15:46
Radio and PodcastLive Radio & Podcasts
Science & Medicine
The burning hole in Gilead's $25B pocket and AbbVie's future in hematology
Fierce editors discuss the discussion around Gilead Sciences' huge cash reserve and the many things the company might buy. Plus, a look back at AbbVie's blockbuster buyout of Pharmacyclics and a thoughtful consideration...
About This Episode
The burning hole in Gilead's $25B pocket and AbbVie's future in hematology is an episode from FierceBiotech Radio. Fierce editors discuss the discussion around Gilead Sciences' huge cash reserve and the many things the company might buy. Pl...
Podcast
This episode belongs to FierceBiotech Radio.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Dec 10, 2015, 19:52 long, audio available.
Related Episodes
Continue listening to more episodes from FierceBiotech Radio.
